Phase IV - a trial of xyrem [sodium oxybate] in the treatment of chronic fatigue syndrome.
Latest Information Update: 21 May 2016
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- 13 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 15 Dec 2011 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Planned number of patients changed from 30 to 31 as reported by ClinicalTrials.gov.